Technetium Tc 99M Disofenin

CHEMBL1200923 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
449.3 g/mol
LogP
Phase
4

Technetium Tc 99m disofenin is a hepatobiliary iminodiacetic acid radiopharmaceutical used for HIDA scintigraphy to evaluate hepatobiliary function, gallbladder emptying, and biliary tract anatomy. See technetium-disofenin for complete pharmacological details. It provides functional imaging of hepatocyte uptake and biliary excretion dynamics.

Masse moléculaire

449,3000 g/mol

TPSA

107,00 Ų

Mécanisme d'action

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mécanisme

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

SMILES

CC(C)C1=C(C(=CC=C1)C(C)C)NC(=O)CN(CC(=O)O)CC(=O)O.[99Tc]

InChI

InChI=1S/C18H26N2O5.Tc/c1-11(2)13-6-5-7-14(12(3)4)18(13)19-15(21)8-20(9-16(22)23)10-17(24)25;/h5-7,11-12H,8-10H2,1-4H3,(H,19,21)(H,22,23)(H,24,25);/i;1+1

Molecular Formula

C18H26N2O5Tc

HBD / HBA

3 / 6

Liaisons Rotatives

9

Atomes Lourds

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

Technetium Tc 99m disofenin is a hepatobiliary iminodiacetic acid radiopharmaceutical used for HIDA scintigraphy to evaluate hepatobiliary function, gallbladder emptying, and biliary tract anatomy. See technetium-disofenin for complete pharmacological details. It provides functional imaging of hepatocyte uptake and biliary excretion dynamics.

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

Yes, Technetium Tc 99M Disofenin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200923. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 11430828. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.